MEDICAMEN BIOTECH
Back to Income Statement
|
MEDICAMEN BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹141 Cr | ₹115 Cr | ₹11,271,608 Cr | ₹126 Cr | ₹123 Cr |
What is the latest Revenue of MEDICAMEN BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹115 Cr |
| Mar2022 | ₹11,271,608 Cr |
| Mar2021 | ₹126 Cr |
| Mar2020 | ₹123 Cr |
How is Revenue of MEDICAMEN BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹141 Cr | 22.02 | |
| Mar2023 | ₹115 Cr | -100.00 | |
| Mar2022 | ₹11,271,608 Cr | 8,980,974.92 | |
| Mar2021 | ₹126 Cr | 2.37 | |
| Mar2020 | ₹123 Cr | - | |
Compare Revenue of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹475.7 Cr | -1.7% | -13.5% | -8.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,192.0 Cr | 0.3% | -4% | -6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,479.0 Cr | 2% | -9.6% | 33.1% | Stock Analytics | |
| CIPLA | ₹125,113.0 Cr | 1.9% | 4.5% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹123,539.0 Cr | 0.6% | 3.6% | 9.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,926.0 Cr | 2% | -1% | -7% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -1.7% |
-13.5% |
-8.8% |
| SENSEX | 1.3% |
-0.8% |
3.2% |
You may also like the below Video Courses